Medical Microinstruments, Inc.

Medical Microinstruments, Inc. (MMI) is the global leader in robotic microsurgery, designing and manufacturing the Symani® Surgical System—a breakthrough robotic platform uniquely engineered for microsurgery and supermicrosurgery. The system provides surgeons unmatched precision, consistency, and control for complex reconstructive and vascular procedures at the micro level. Core Product: The Symani Surgical System features the NanoWrist® instrument platform, which incorporates the world's smallest robotic wrist and replicates natural hand movements to enable precise intraoperative tasks including dissection, anastomosis, and supermicrosurgical repair. The company has introduced the world's first microsurgical suture designed specifically for robotic application. Clinical Applications: Symani supports multiple surgical specialties, including lymphatic reconstruction (lymphovenous anastomosis for lymphedema), autologous breast cancer reconstruction, head and neck cancer reconstruction, and trauma-related microvascular repair. Published clinical evidence demonstrates superior outcomes: 100% anastomosis patency on 2mm vessels versus 80% with manual techniques, 86% of lymphedema patients achieving limb-volume reduction, and >50% reduction in flap loss rates compared to manual microsurgery. Regulatory Status: The Symani Surgical System is FDA-authorized for use in the United States and CE-marked in Europe. The system is manufactured in Pisa, Italy. Company Position: MMI positions itself at the intersection of advanced robotics and digital innovation, targeting academic medical centers, specialty surgical centers, and plastic and reconstructive surgery programs performing complex microsurgery. The company provides surgeon training and certification, reimbursement support, and technical customer support.